Synthesis of peptidomimetic conjugates of cyclic nucleoside phosphonates

Current Protocols in Nucleic Acid Chemistry

Volumn , Issue SUPPL.43, 2010, Pages

  Serpi, Michaela ^a   Krylov, Ivan S ^a   Zakharova, Valeria M ^a   McKenna, Charles E ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

(S) HPMPA; (S) HPMPC; Acyclic nucleoside phosphonates; Peptidomimetic prodrugs

Indexed keywords

AMINO ACID; CIDOFOVIR; CYCLIC NUCLEOSIDE PHOSPHONATE; DIPEPTIDE; ETHYLENE GLYCOL; GLYCOL; PEPTIDOMIMETIC AGENT; PHOSPHONIC ACID DERIVATIVE; SERINE; THREONINE; TYROSINE; UNCLASSIFIED DRUG;

ARTICLE; ESTERIFICATION; PRIORITY JOURNAL; SOLID PHASE SYNTHESIS; SYNTHESIS;

EID: 79953286044     PISSN: 19349270     EISSN: 19349289     Source Type: Journal    
DOI: 10.1002/0471142700.nc1504s43     Document Type: Article

References (16)

1. Ariza, M.E. 2005. Current prodrug strategies for the delivery of nucleotides into cells. Drug Des. Rev. Online 2:373-387.
2. De Clercq, E. 2007. The acyclic nucleoside phosphonates from inception to clinical use: Historical perspective. Antiviral Res. 75:1-13.
3. De Clercq, E. and Holý, A. 2005. Acyclic nucleoside phosphonates: A key class of antiviral drugs. Nat. Rev. Drug Discov. 4:928-940.
4. Eriksson, U., Hilfinger, J.M. Kim, J.-S., Mitchell, S., Kijek, P., Borysko, K. Z., Breitenbach, J.M., Drach, J.C., Kashemirov, B.A., and McKenna, C.E. 2007. Synthesis and biological activation of an ethylene glycol-linked amino acid conjugate of cyclic cidofovir. Bioorg. Med. Chem. Lett. 17:583-586.
5. Eriksson, U., Peterson, L.W., Kashemirov, B.A., Hilfinger, J.M., Drach, J.C., Borysko, K.Z., Breitenbach, J.M., Kim, J.S., Mitchell, S., Kijek, P., and McKenna, C.E. 2008. Serine peptide phosphoester prodrugs of cyclic cidofovir: Synthesis, transport, and antiviral activity. Mol. Pharmaceutics 5:598-609.
6. Holý, A. 2003. Phosphonomethoxyalkyl analogs of nucleotides. Curr. Pharm. Des. 9:2567-2592.
7. Hostetler, K.Y. 2009. Alkoxyalkyl prodrugs of acyclic nucleoside phosphonates enhance oral antiviral activity and reduce toxicity: Current state of the art. Antiviral Res. 82:A84-A98.
8. Krečmerová, M., Holý, A., Andrei, G., Pomeisl, K., Tichý, T., B̌rehová, P., Masojídková, M., Dračínský, M., Pohl, R., Laflamme, G., Naesens, L., Hui, H., Cihlar, T., Neyts, J., De Clercq, E., Balzarini, J., and Snoeck, R. 2010. Synthesis of ester prodrugs of 9-(S)-[3-hydroxy -2-(phosphonomethoxy)propyl]-2,6-diaminopurine (HPMPDAP) as anti-poxvirus agents. J. Med. Chem. 53:6825-6837.
9. Krylov, I.S., Peterson, L.W., Kashemirov, B.A., Breitenbach, J.M., Borysko, K.Z., Drach, J.C., Kim, J.S., Hilfinger, J.M., and McKenna, C.E. 2009. In vitro transport, activation and antiviral evaluationofnew HPMPA prodrugs synthesized on a solid support. Antiviral Res. 82:A75.
10. McKenna, C.E., Peterson, L.W., Kashemirov, B.A., Serpi, M., Mitchell, S., Kim, J.S., Hilfinger, J.M., and Drach, J.C. 2009. New peptidomimetic prodrugs of acyclic and cyclic cidofovir: SAR studies of chemical and enzymatic activation mechanisms. Antiviral Res. 82:A75.
11. Mendel, D.B., Cihlar, T., Moon, K., and Chen, M.S. 1997. Conversion of 1-[((S)-2-hydroxy-2-oxo-1,4,2-dioxaphosphorinan-5-yl)methyl]cytosine to cidofovir by an intracellular cyclic CMP phosphodiesterase. Antimicrob. Agents Chemother. 41:641-646.
12. Novachek, K.A. and Myers, A.I. 1996. A convenient procedure for the reduction of S-(+)silyl serine methyl ester to chiral serinol derivatives. Tetrahedron Lett. 37:1743-1746.
13. Peterson, L.W. and McKenna, C.E. 2009. Prodrug approaches to improving the oral absorption of antiviral nucleotide analogues. Expert Opin. Drug Deliv. 6:405-420.
14. Peterson, L.W., Sala-Rabanal, M., Krylov, I.S., Serpi, M., Kashemirov, B.A., and McKenna, C.E. 2010 Serine side chain-linked peptidomimetic conjugates of cyclic HPMPC and HPMPA: Synthesis and interaction with hPEPT1. Mol. Pharm. In press.
15. Soul-Lawton, J., Seaber, E., On, N., Wootton, R., Rolan, P., and Posner, J. 1995. Absolute bioavailability and metabolic disposition of valaciclovir, the L-valyl ester of acyclovir, following oral administration to humans. Antimicrob. Agents Chemother. 39:2759-2764.
16. Zakharova, V.M., Krylov, I.S., Serpi, M., Kashemirov, B.A., and McKenna, C.E. 2010. Approaches to tyrosine-linked peptidomimetic prodrugs of(S)-HPMP-based acyclic nucleoside phosphonates. Phosphorus, Sulfur, Silicon and the Rel. Elem. Accepted.